Editorial Policy

Every piece of clinical or product content begins with a scoped brief, is drafted by a subject-matter writer, and passes through structured review before publication.

Clinical content is reviewed by qualified members of the ScribeMDPro Medical Advisory Board prior to publication and revisited on a recurring schedule.

Claims are cross-checked against primary literature, peer-reviewed guidelines, and reputable clinical references before publication.

Where relevant, we cite the source guideline, study, or professional body so readers can verify claims and follow up independently.

We prefer high-quality evidence: systematic reviews, guidelines, and randomised trials — and label lower-certainty statements accordingly.

Editorial decisions are independent of commercial partnerships. Sponsored or partner-produced content, when present, is labelled clearly.

AI may be used to draft or translate content. A human editor is always accountable for the final version, and clinical material is medically reviewed.

Every clinical article shows a "last reviewed" date so readers can judge how current the guidance is.